Ping An Biomedical , Ltd. Overview
Get informed when a big investor buys or sells
+ Follow-0.60
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for PASW is -0.6. That is below the sector sector average of 24.62. Investors often review this figure alongside Ping An Biomedical , Ltd.'s historical trend and sector peers before judging valuation or financial health.
Against its sector companies, PASW currently prints -0.6 for P/E ratio, while the sector average sits near 24.62. That is roughly 102.4% below the sector mean. Large gaps often invite a closer look at Ping An Biomedical , Ltd.'s growth, margins, and balance sheet.
A P/E ratio of -0.6 for Ping An Biomedical , Ltd. is not 'good' or 'bad' on its own. Compare it with the peer average (24.62) and with PASW's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting PASW's P/E ratio (-0.6), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
